Literature DB >> 20538343

Functional impairment in bipolar II disorder: is it as disabling as bipolar I?

A R Rosa1, C M Bonnín, G H Vázquez, M Reinares, B Solé, R Tabarés-Seisdedos, V Balanzá-Martínez, A González-Pinto, J Sánchez-Moreno, E Vieta.   

Abstract

INTRODUCTION: It is well established that patients with bipolar disorder experience functional impairment even in remission. Nevertheless, bipolar II disorder remains understudied because most investigations to date include only bipolar I patients or just a small sample of bipolar II patients, without explicitly comparing both subtypes of disorder. The main objective of the current report is to evaluate overall and multiple domains of functioning, specifically in bipolar II disorder compared to patients with bipolar I disorder and healthy subjects.
METHODS: 233 subjects from 3 groups were compared: bipolar I patients (n=106), bipolar II patients (n=66) and healthy controls (n=61). Bipolar patients meeting criteria of remission were recruited at the Hospital Clinic of Barcelona and at different study sites in Argentina. All participants were assessed with 17-item Hamilton Depression Rating Scale (HAM-D), Young Mania Rating Scale (YMRS) and the Functioning Assessment Short Test (FAST). Clinical and sociodemographic data were also recorded.
RESULTS: Both subgroups of patients, bipolar I and bipolar II, showed lower overall functioning (p<0.001) and in each domain of the FAST scale (all, p<0.001) when compared to the healthy control group. Tukey post hoc test revealed that bipolar II patients scored worse in the cognitive domain compared to bipolar I patients. However, after controlling for potential confounding variables, this difference disappeared and only older age (p<0.005) and HAM-D scores (p<0.001) remained significant.
CONCLUSIONS: Our results suggest that bipolar II patients are as disabled as bipolar I patients. This may be explained, in part, because bipolar II patients experience greater lifetime residual depressive symptoms than the bipolar I subgroup, which may have particular impact on cognitive domains of functioning.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20538343     DOI: 10.1016/j.jad.2010.05.014

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  11 in total

1.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

2.  Bipolar II Disorder: Frequent, Valid, and Reliable.

Authors:  Eduard Vieta
Journal:  Can J Psychiatry       Date:  2019-08       Impact factor: 4.356

3.  Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.

Authors:  K E Burdick; M Russo; S Frangou; K Mahon; R J Braga; M Shanahan; A K Malhotra
Journal:  Psychol Med       Date:  2014-03-11       Impact factor: 7.723

4.  Long-term work disability due to type I and II bipolar disorder: findings of a six-year prospective study.

Authors:  Petri Arvilommi; Sanna Pallaskorpi; Outi Linnaranta; Kirsi Suominen; Sami Leppämäki; Hanna Valtonen; Erkki Isometsä
Journal:  Int J Bipolar Disord       Date:  2022-07-11

5.  Neurological and psychiatric diseases and their unique cognitive profiles: implications for nursing practice and research.

Authors:  David E Vance; Joan E Dodson; Jason Watkins; Bridgett H Kennedy; Norman L Keltner
Journal:  J Neurosci Nurs       Date:  2013-04       Impact factor: 1.230

6.  The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Shiou-Lan Chen; Yun-Hsuan Chang; Po-See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Yi-Hsin Yang; Ru-Band Lu; Cheng-Sheng Chen
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

7.  Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment.

Authors:  Jessica Madera; Pedro Such; Peter Zhang; Ross A Baker; Iria Grande
Journal:  Neuropsychiatr Dis Treat       Date:  2019-08-15       Impact factor: 2.570

8.  Validity and Reliability of the Italian Version of the Functioning Assessment Short Test (FAST) in Bipolar Disorder.

Authors:  Maria Francesca Moro; Francesc Colom; Francesca Floris; Elisa Pintus; Mirra Pintus; Francesca Contini; Mauro Giovanni Carta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2012-08-09

9.  Neurocognitive features in subgroups of bipolar disorder.

Authors:  Sofie Ragnhild Aminoff; Tone Hellvin; Trine Vik Lagerberg; Akiah Ottesen Berg; Ole A Andreassen; Ingrid Melle
Journal:  Bipolar Disord       Date:  2013-03-25       Impact factor: 6.744

10.  Add-on Lamotrigine Treatment for Subsyndromal Depression after Manic or Mixed States in Bipolar Disorder Improved the Quality of Life.

Authors:  Katsumasa Muneoka; Katsushi Kon; Masaharu Kawabe; Rui Ui; Taichi Miura; Touta Iimura; Shou Kimura
Journal:  Case Rep Med       Date:  2012-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.